The Australasian Professional Society on Alcohol and other Drugs

News & Media

Long Walk to Treatment

Dqi itdWsAAFCcqDear friends and colleagues,

This is a last-minute call for your help in the culmination of Uniting’s “Long Walk to Treatment” from Dubbo to Sydney. This was done to highlight the lack of access to life saving drug treatment that occurs in Australia where 50% of pepoe who present seeking help with alcohol or drug problems can’t get it. An event tomorrow,  Friday November 2 will start at St Stephens Uniting Church in Macquarie St and cross the road to deliver our statement, from the Uniting Church Moderator to NSW Parliament.

Our urgent ask of you at this point is:

  1. Please be there tomorrow, 12.30 at NSW Parliament House if you can – details and registration link below. We need to show parliament how strongly we feel about this!
  2. Please URGENTLY sign to draw the line (link below) – and follow up with your networks. We need more signatures so they know it’s important to people.

Here are the details:

Long Walk to Treatment arrives in Sydney this Friday

It’s taken 15 days and more than half a million steps for our 100-walkers to make the journey from Dubbo to Sydney.

 

You are invited to St Stephens Uniting Church this Friday 2 November at 12:30pm to attend this milestone occasion. Be inspired by the people who have walked from Dubbo and hear the stories they want to share.

As part of the event, the Uniting Church Moderator will walk across the road to NSW Parliament to hand the Long Walk to Treatment baton over for the final time.

Invitation to attend: Long Walk to Treatment, Sydney

  • · Time: 12:30pm – 1:30pm
  • · Venue: St Stephen’s Church, 197 Macquarie St, Sydney (opposite NSW Parliament | map)
  • · RSVP: register your attendance by clicking here

Show your support for drug reform

There’s still time to draw the line on drug policy by adding your online signature of support at www.fairtreatment.org/walk .

Thanks for your support.

 

APSAD and Drug and Alcohol Review will be launching a new award at the APSAD Conference

APSAD and Drug and Alcohol Review (the Society’s official journal) will be launching a new award at the APSAD Conference Early Career Researchers (ECR)  Networking Breakfast on Tuesday 6 November. 


The award will be for the most cited paper published in 2015-16 by an ECR in Drug and Alcohol Review. The award is recognition only, providing a measure of esteem that can be used for ECR career development - a great addition to your CV!


Eligible papers will be those that are:

  • Published in an issue of Drug and Alcohol Review in 2015-2016 (Volumes 34 & 35);
  • First-authored by a current APSAD member, who met APSAD ECR criteria at the time of
  • publication*;
  • An original report, brief report, or comprehensive review (i.e. not letters/commentaries).

*Not more than 5 years post last postgraduate degree and have been working in the field as a researcher or scientist for less than 10 years, career disruptions excluded.

The winner of this award will be determined through the APSAD membership database, so to be in the running, make sure your APSAD membership is current. If you are unsure of your membership status please contact the This email address is being protected from spambots. You need JavaScript enabled to view it..

If you think you might be eligible for this award but are not a member, it’s not too late to join!

You can apply for membership here – please be sure to list the year your PhD was completed (conferred) on the application form. If you supervise or work with ECRs, please share these details with them so they can make sure their APSAD Membership is current. For further information on APSAD Membership and the ECR Group.  

 

Webinar 2: The Non-Medical Use of Anabolic-Androgenic Steroids: The Challenges Faced by the AoD & Medical Fields

Webinar Banner edited

Tuesday 30 October

Webinar 2: The Non-Medical Use of Anabolic-Androgenic Steroids: The Challenges Faced by the AoD & Medical Fields

Dr Matthew Dunn
Senior Lecturer, Faculty of Health, School of Health & Social Development, Deakin University.

There is increasing interest in the non-medical use of anabolic-androgenic steroids (AAS), with some suggesting we are facing a ‘looming public health problem’. The use of these and other performance and image enhancing substances pose some unique challenges for the AOD and medical fields.

This webinar will:

  • Provide an overview of the types of substances people use;
  • Outline the purposes for use and the contexts within which they are used;
  • Present the short- and long-term effects experienced; and
  • Consider how the medical community can engage this group.

Register in advance for this webinar: https://racp.zoom.us/webinar/register/WN_U7zIj_jtR46KQMTczGJypw

After registering, you will receive a confirmation email containing information about joining the webinar.

This webinar is part of the Specialty Society Webinar Service pilot that is being undertaken by the Royal Australasian College of Physicians in partnership with its affiliated speciality societies.

 

Nicotine Addiction & Smoking Cessation Training Course

Gain in-depth knowledge and skills in nicotine addiction and smoking cessation to work in primary and allied healthcare as a tobacco treatment and smoking cessation specialist.

Hosted by A/Prof Renee Bittoun Tobacco Treatment Specialist, Adjunct Associate Professor Medical School, University of Notre Dame Australia, along with other experts in the field of smoking cessation. A/Prof Bittoun has been teaching this coursefor over 15 years, regularly updating the content and has many years of experience in clinical practice and professional training regarding smoking cessation.

Topics: Causes, consequences, treatment and research of smoking cessation, nicotine addiction and appropriate evidence based smoking cessation techniques in practical application. Our aim is to improve the implementation and evaluation of programs in smoking cessation. This three day course includes a USB stick with course materials and a certificate of attendance is awarded on completion.

 Date:  23 - 25 October 2018
 Time:  9am – 5pm
 Location: Woolcock Institute of Medical Research,
Level 5 431 Glebe Point Rd,
Glebe, NSW 2037
Cost: $1,870 incl GST
Catering provided


REGISTER ONLINE: https://smokingcessationoct2018.eventbrite.com.au

Alternatively DOWNLOAD and complete the registration form.

 

Drug Trends, NDARC: Two Research Fellow A/B and one Research Officer position

The National Drug and Alcohol Research Centre are currently advertising two Research Fellow A/B positions and one Senior Research Officer position to work on Drug Trends. These positions are a unique opportunity to contribute to this program of research, shaping the way drug use and harms are monitored in Australia into the future. The two Research Fellows will be involved in strengthening various aspects of the program, bringing innovation in methodology, statistical analyses, dissemination and communication of findings. 

For further information and to apply, please click here:

Applications close 11 pm Wednesday 15th August. Please feel free to direct any queries to Amy Peacock (This email address is being protected from spambots. You need JavaScript enabled to view it.; +61 2 9385 0282)

 

Interested in participating in a research study on ecstasy use?

This study involves completing a 20-minute online anonymous survey which will ask questions about your experiences with drug use, personality, mental health and basic demographic information. Your responses will be kept anonymous and confidential. Note you must be at least 18 years old to enter.

This research is being conducted by Sally Meikle for a Psychology Honours degree, under the supervision of Dr. Gillinder Bedi and A/Prof Olivia Carter.

All participants will be given the option to enter a prize draw of two $50 AUD gift vouchers.

Open the link below to find out more and participate

https://melbourneuni.au1.qualtrics.com/jfe/form/SV_20pSDSPweqUzuvj

 

ecstasy survey

 

New Thoughts of Substance Podcast from the ECR sub-committee

On this episode of Thoughts Of Substance, Dr Christina Marel is talking to the 2007 winner of the APSAD Early Career Award, Associate Professor Katherine Mills, about some of her career successes and challenges. Has it all been smooth sailing? What were some of the biggest obstacles she’s encountered along the way to becoming an independent researcher? 

https://soundcloud.com/user-960069631-756237016/3-thoughts-of-substance

 

Thought of Substance podcast slide

 

Call for Late Breaking abstract submission is OPEN

Now Calling for Late Breaking Abstract Submissions
 
The Scientific Advisory Committee invites the submission of Late-Breaking abstracts for presentation at the APSAD Auckland 2018 Conference.
 
The Late Breaking sessions are lively and informative with fast-paced 5-minute presentations. The sessions are dedicated to new information or important findings not fully available before the general abstract deadline.The Late Breaking presentations are held as standalone sessions, this is an opportunity to address all conference delegates, and is one of the popular sessions at the conference.  
 
Abstracts must be submitted by Sunday 12 August 2018, there will be no extension to the submission closing date.
 
Please note that the Late Breaking Abstract deadline is NOT an extension of the general abstract submission deadline.
 
For further information about the Late Breaking Session and how to submit visit the conference website
 
 
 

2018 NDRI Annual Symposium

The National Drug Research Institute (NDRI) is bringing its annual symposium to Melbourne for the first time 

NDRI invites you to

2018 NDRI Annual Symposium – Alcohol and Other Drug Research, Policy and Practice

Date: Thursday 22 November 2018

Venue: RACV City Club, Bourke St, Melbourne

Early Bird Rate: $210 (inc. GST)

FOR EARLY BIRD REGISTRATIONS AND MORE INFORMATION CLICK HERE

  • International keynote speaker Professor Tom Decorte, from Ghent University, Belgium, outlines the latest international developments in regulating cannabis
  • An outstanding panel of national and international drug policy experts debate global developments in cannabis policy and regulation – and their impact on Australia
  • Perth and Melbourne-based NDRI researchers present the latest innovative research and findings aimed at preventing and reducing alcohol and other drug-related harm
  • A range of alcohol and other drug topics discussed including take-home naloxone, alcohol policy, justice health, school drug education and addressing stigma
  • World-first trial 
  • More speakers and symposium information announced soon

Note: RACV City Club is offering discounted accommodation rates to symposium attendees.

To enquire about accommodation rates, This email address is being protected from spambots. You need JavaScript enabled to view it. 

To find out more about NDRI’s research, visit our new website or follow us at @NDRIau

NDRI

 

ECU Study on Microdosing Psychedlics

Have you ever with

Microdosing

What we are trying to discover: The purpose of the study is to explore wellbeing, stress, anxiety and depressive symptoms in people who microdose compared with a group practising an activity that has similar aims to microdosing.

Why? While there is growing research demonstrating the therapeutic potential of psychedelic drugs, there is limited research on microdosing. Anecdotal reports of microdosing are consistent with research on the therapeutic effects of psychedelics in larger doses. Microdosing might provide the beneficial therapeutic effects associated with psychedelics without the intense experience of a full dose.

https://ecuau.qualtrics.com/jfe/form/SV_9pK4Rmqc624XWcJ

 

Subcategories